Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Oct 2022 for Biohaven Pharmaceutical Holding Co Ltd., €3.4M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles Conway: trading record in brief
Charles Conway is a declared insider of Biohaven Pharmaceutical Holding Co Ltd. (senior executive), with filings sourced from SEC (Form 4). Between 23 November 2021 and 3 October 2022, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 October 2022 came the latest disclosure, a transaction for €3.4M in Biohaven Pharmaceutical Holding Co Ltd. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Conway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
22,362 shares@ US$148.5083.5% of flowCommon SharesSEC:0001562180-22-006950:0
3,750 shares0Common SharesSEC:0001562180-22-000355:0
10,000 shares@ US$37.549.0% of flowCommon SharesSEC:0001562180-21-007297:0
3 of 3 declarations
